At Theragen, we strive to improve patient care and surgical fusion outcomes via non-invasive therapeutic electrical stimulation, advanced patient insights, and exceptional customer service. Theragen recently launched ActaStim-S, the smallest, most digitally capable, and data-driven non-invasive bone growth stimulator in over 2-decades. ActaStim-S assumed first-mover status by combining all-day wearability, proven capacitive coupling therapy, and automated daily clinical data capture to engage patients, enable compliance, and generate insight reports to inform clinicians when patients need guidance to stay on their healing journey.
2014
Theragen raised undisclosed on March 23, 2017